Диабетическая нейропатия: новые подходы к диагностике и лечению

Диабетическая нейропатия – одно из наиболее тяжёлых осложнений сахарного диабета, существенно ухудшающее качество жизни пациентов. В статье представлены современные подходы к диагностике и лечению этого состояния, включая использование инновационных технологий, таких как генная и клеточная терапия, нанотехнологии и искусственный интеллект. Особое внимание уделено профилактике и междисциплинарному подходу, направленному на улучшение прогнозов пациентов. 

1. Callaghan BC, Gallagher G, Fridman V, Feldman EL. Diabetic neuropathy: what does the future hold? Diabetologia. 2020;63(5):902–917. https://doi.org/10.1007/s00125-020-05085-9.

2. Ponirakis G, Dabbah MA, Sankaranarayanan A, et al. Corneal confocal microscopy detects small fiber neuropathy in asymptomatic patients with type 2 diabetes. PLoS One. 2017;12(7):e0180175. https://doi.org/10.1371/journal.pone.0180175.

3. Jiang Y, Hill MA, Kowluru RA. Emerging biomarkers for diabetic peripheral neuropathy. Curr Diab Rep. 2020;20(11):64. https://doi. org/10.1007/s11892-020-01350-7.

4. Yang Z, Chen R, Zhang Y, Huang Y, Li J. Treatment for painful diabetic peripheral neuropathy: a meta-analysis. Int J Clin Pract. 2021;75(9):e14131. https://doi.org/10.1111/ijcp.14131.

5. Pieralice S, Vari R, Minutolo A, Maurizi AR, et al. Biomarkers of response to alpha-lipoic acid ± palmitoylethanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy. Endocrine. 2019;66(1):145–153. https://doi.org/10.1007/s12020-019-01917-w.

6. Morgenstern J, Groener JB, Jende JME, Kurz FT, et al. Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia. 2021;64(6):1324–1336. https://doi.org/10.1007/s00125-021-05557-6.

7. Tigchelaar C, van Zuylen ML, Hulst A, et al. Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway. Diabetologia. 2022;65:1098–1107. https://doi.org/10.1007/s00125-022-05693-7.

8. Zglejc-Waszak K, Schmidt AM, Juranek JK. The receptor for advanced glycation end products and its ligands’ expression in OVE26 diabetic sciatic nerve during the development of length-dependent neuropathy. Neuropathology. 2023;43(2):175–185. https://doi.org/10.1111/neup.12852.

9. Wan L, Bai X, Zhou Q, et al. The AGEs/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration. Int J Biol Sci. 2022;18(3):809–825. https://doi.org/10.7150/ijbs.63219.

10. Wu B, Guo Y, Chen Q, et al. The role of inflammation in the pathogenesis of diabetic peripheral neuropathy. Diabetes Ther. 2025;16(1):e12345. https://doi.org/10.1007/s13300-025-01699-7.

11. Jende JME, Mooshage C, Kender Z, et al. Sciatic nerve microvascular permeability in type 2 diabetes decreased in patients with neuropathy. Ann Clin Transl Neurol. 2022;9(6):830–840. https://doi.org/10.1002/acn3.51563.

12. Dillon BR, Ang L, Pop-Busui R. Spectrum of diabetic neuropathy: new insights in diagnosis and treatment. Annu Rev Med. 2024;75:293–306. https://doi.org/10.1146/annurev-med-043021-033114.

13. Corrà MF, Sousa M, Reis I, et al. Advantages of an automated method compared with manual methods for the quantification of intraepidermal nerve fiber in skin biopsy. J Neuropathol Exp Neurol. 2021;80(7):685–694. https://doi.org/10.1093/jnen/nlab045.

14. Midena E, Frizziero L, Midena G, Pilotto E. Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2021;259(12):3549–3560. https://doi.org/10.1007/s00417-021-05285-y.

15. Udaondo P, Hernández C, Briansó-Llort L, et al. Usefulness of liquid biopsy biomarkers from aqueous humor in predicting anti-VEGF response in diabetic macular edema: results of a pilot study. J Clin Med. 2019;8(11):1841. https://doi.org/10.3390/jcm8111841.

16. Băicus C, Purcărea A, von Elm E, Delcea C, Furtunescu F. Alpha-lipoic acid for diabetic peripheral neuropathy. Cochrane Database Syst Rev. 2024;(2):CD012967. https://doi.org/10.1002/14651858.CD012967.pub2.

17. Hotta N, Kawamori R, Fukuda M, Shigeta Y; Aldose Reductase Inhibitor-Diabetes Complications Trial Study Group. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabet Med. 2012;29(12):1529–1533. https://doi.org/10.1111/j.1464-5491.2012.03684.x.

18. Hoyng SA, De Winter F, Gnavi S, de Boer R, Boon LI, Korvers LM, et al. A comparative morphological, electrophysiological and functional analysis of axon regeneration through peripheral nerve autografts genetically modified to overexpress BDNF, CNTF, GDNF, NGF, NT3 or VEGF. Exp Neurol. 2014;261:578–593. https://doi.org/10.1016/j.expneurol.2014.08.002.

19. Cheng Y, Wang H, Li M. The promise of CRISPR/Cas9 technology in diabetes mellitus therapy: how gene editing is revolutionizing diabetes research and treatment. J Diabetes Complications. 2023;37(1):108524. https://doi.org/10.1016/j.jdiacomp.2023.108524

20. Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–350. https://doi. org/10.1056/NEJMoa032782.

21. Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012;26(5):424–429. https://doi.org/10.1016/j.jdiacomp.2012.05.007.

22. Moxey PW, Gogalniceanu P, Hinchliffe RJ, et al. Lower extremity amputations – a review of global variability in incidence. Diabet Med. 2011;28(10):1144–1153. https://doi.org/10.1111/j.1464-5491.2011.03279.x.

23. Davidson EP, Holmes A, Coppey LJ, Yorek MA. Effect of combination therapy consisting of enalapril, alpha-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat. Eur J Pharmacol. 2015;765:258–267. https://doi. org/10.1016/j.ejphar.2015.08.015.

24. Najafi R, Sharifi AM, Hosseini A. Protective effects of alpha lipoic acid on high glucose-induced neurotoxicity in PC12 cells. Metab Brain Dis. 2015;30(3):731–738. https://doi.org/10.1007/s11011-014-9625-1.